Is it dangerous to inject magnetic resonance contrast media into the subarachnoid space?
Skalpe
I O
IO
D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects; D003287:Contrast Media / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D007089:Image Enhancement; D007278:Injections, Spinal; D007455:Iodine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D008279:Magnetic Resonance Imaging; D008536:Meglumine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D051381:Rats; D013346:Subarachnoid Space
D003287:Contrast Media; D009942:Organometallic Compounds; C064572:gadobenic acid; D008536:Meglumine; D007455:Iodine; D005682:Gadolinium